Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02240797 · ClinicalTrials.gov registry record
Kappa Opioid Receptor Imaging in Anorexia
A clinical trial, sponsored by NYU Langone Health.
- Terminated
- Registry status
- 7
- Enrollment target
NCT02240797 is a clinical trial that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 7 participants.
The verdict
NCT02240797 was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to use positron emission tomography (PET) imaging and magnetic resonance imaging (MRI) to understand the brain function of individuals with anorexia nervosa and healthy controls.
Interventions
- OTHER Positron emission tomography (PET) imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02240797
The ClinicalTrials.gov registry entry for NCT02240797 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Positron emission tomography (PET) imaging is the first listed.
NCT02240797 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02240797 about?
NCT02240797 is a clinical study titled "Kappa Opioid Receptor Imaging in Anorexia". The purpose of this study is to use positron emission tomography (PET) imaging and magnetic resonance imaging (MRI) to understand the brain function of individuals with anorexia nervosa and healthy controls.
What is the current status of trial NCT02240797?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2014-09. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02240797?
The interventions under investigation include: Positron emission tomography (PET) imaging (OTHER).
Who is sponsoring clinical trial NCT02240797?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.